Global Conjugated Monoclonal Antibodies Markets Report 2021: Focus on Adcetris, Kadcyla, Cleavable Linker, & Non-cleavable Linker - Forecast to 2025 & 2030
January 10, 2022 05:13 ET
|
Research and Markets
Dublin, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The "Conjugated Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
Vir Biotechnology Announces New Research Describing the Structural Basis of SARS-CoV-2 Omicron Immune Evasion and Receptor Engagement
December 31, 2021 08:47 ET
|
Vir Biotechnology, Inc.
– Growing body of evidence validates Vir’s approach of targeting a highly conserved region of the spike protein – – Together with recent pseudo- and live virus results, additional preclinical data...
The Worldwide Culture Media Industry is Expected to Reach $13+ Billion by 2030
December 29, 2021 06:53 ET
|
Research and Markets
Dublin, Dec. 29, 2021 (GLOBE NEWSWIRE) -- The "Culture Media Market by Type, Application, Research Type, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been...
At 9% CAGR, Global Targeted Therapy Market to Surpass US$ 180.3 Billion by 2028, Says Coherent Market Insights (CMI)
December 28, 2021 09:10 ET
|
CMI
SEATTLE, Dec. 28, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global targeted therapy market is estimated to be valued at US$ 98.6 billion in 2021 and is expected to exhibit...
Dyadic Announces a NIIMBL Coronavirus Grant Under the White House’s American Rescue Plan
December 22, 2021 09:12 ET
|
Dyadic International, Inc.
JUPITER, Fla., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further...
Global GVHD Market Landscape Report, 2030: Epidemiology, Emerging Drugs, Market Shares of Therapies, Drivers & Barriers, Unmet Needs, Major Players & SWOT Analysis
December 21, 2021 08:33 ET
|
Research and Markets
Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GVHD) - Market Insight, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering....
Global Stat Inhibitors Pipeline Landscape 2021 Featuring Over 25 Drugs and Companies, Including Bio-Path, Jiangsu Hengrui Medicine Co, Reata Pharmaceuticals, Tvardi Therapeutics, and Purple Biotech
December 20, 2021 06:58 ET
|
Research and Markets
Dublin, Dec. 20, 2021 (GLOBE NEWSWIRE) -- The "Stat Inhibitors - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides comprehensive...
Dyadic Announces Research, License and Collaboration Agreement with Janssen for the Manufacture of Therapeutic Protein Candidates using its C1 Platform
December 17, 2021 07:00 ET
|
Dyadic International, Inc.
JUPITER, Fla., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further...
Tenosynovial Giant Cell Tumors, Global Pipeline Insight 2021 - Players, Drug Profiles, Therapeutics Assessment, Inactive Pipeline Products, and More
December 17, 2021 06:58 ET
|
Research and Markets
Dublin, Dec. 17, 2021 (GLOBE NEWSWIRE) -- The "Tenosynovial Giant Cell Tumors - Pipeline Insight, 2021" clinical trials has been added to ResearchAndMarkets.com's offering. This report provides...
Global TRAIL Receptor 2 Agonists Pipeline Landscape Report 2021
December 17, 2021 06:53 ET
|
Research and Markets
Dublin, Dec. 17, 2021 (GLOBE NEWSWIRE) -- The "TRAIL Receptor 2 Agonists - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides...